TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Biovac Sverige AB
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
36,578
|
44,060
|
42,485 |
| Financial expenses |
56
|
129
|
71 |
| Earnings before taxes |
517
|
1,517
|
-1,495 |
| EBITDA |
676
|
1,775
|
-1,297 |
| Total assets |
12,811
|
11,921
|
11,653 |
| Current assets |
10,994
|
9,826
|
9,408 |
| Current liabilities |
7,856
|
7,372
|
8,606 |
| Equity capital |
4,955
|
4,549
|
3,047 |
| - share capital |
75
|
75
|
75 |
| Employees (average) |
8
|
9
|
9 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
38.7%
|
38.2%
|
26.1% |
| Turnover per employee |
4,572
|
4,896
|
4,721 |
| Profit as a percentage of turnover |
1.4%
|
3.4%
|
-3.5% |
| Return on assets (ROA) |
4.5%
|
13.8%
|
-12.2% |
| Current ratio |
139.9%
|
133.3%
|
109.3% |
| Return on equity (ROE) |
10.4%
|
33.3%
|
-49.1% |
| Change turnover |
-7,482
|
1,575
|
-203 |
| Change turnover % |
-17%
|
4%
|
0% |
| Chg. No. of employees |
-1
|
0
|
1 |
| Chg. No. of employees % |
-11%
|
0%
|
13% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.